Cost-utility analysis of loxenatide versus DPP-4 inhibitors in Chinese patients with type 2 diabetes at high cardiovascular risk - Longbing Lai; Fengning Chuan; Qiuhong Huang; Na Xiong; Chuan Peng; Ruobei Zhao; Jianjuan Sun; Qiang Liu; Jiangang Lu (Frontiers in Public Health, 2026)